Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

6 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A
5(45.5%)
Phase 4
5(45.5%)
Phase 3
1(9.1%)
11Total
N/A(5)
Phase 4(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Role: collaborator

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT07447297Not ApplicableRecruiting

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT04769362Phase 4Recruiting

Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Role: collaborator

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT03030495Active Not Recruiting

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

Role: collaborator

NCT05400785Not ApplicableCompleted

Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning

Role: collaborator

NCT06218485Not ApplicableRecruiting

FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease

Role: collaborator

NCT03993236Phase 4Completed

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Role: collaborator

NCT06305572Completed

Diagnostic Accuracy of Quantitative Flow Ratio

Role: collaborator

NCT06153927Completed

Diagnostic Performance of On-site Automatic Coronary Computed Tomography Angiography-derived Fractional Flow Reserve

Role: collaborator

NCT02936232Recruiting

Severe Sepsis and Septic Shock Registry

Role: collaborator

NCT06104033Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Role: collaborator

NCT01946815Phase 3Completed

Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

Role: collaborator

NCT04265443Completed

Prognostic Perspective of Invasive Hyperemic and Non-Hyperemic Physiologic Indices Measured After Percutaneous Coronary Intervention

Role: collaborator

NCT04304677Completed

Automated Algorithm Detecting Physiologic Major Stenosis and Its Relationship With Post-PCI Clinical Outcomes

Role: collaborator

NCT03591328Unknown

Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study

Role: collaborator

NCT01056172Phase 4Unknown

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Role: collaborator